News summarySEC EDGARNov 2, 2026, 12:00 PM
Xeris Biopharma, 8-K (5.02, 7.01, 9.01): director or officer change
Xeris Biopharma appointed Menassie M. Taddese to its Board of Directors, effective November 2, 2026, and named him to the Audit Committee.
Loading...
Xeris Biopharma appointed Menassie M. Taddese to its Board of Directors, effective November 2, 2026, and named him to the Audit Committee.